R. Stancampiano et A. Argiolas, PROTEOLYTIC CONVERSION OF OXYTOCIN INVIVO AFTER MICROINJECTION IN THERAT HIPPOCAMPUS, Peptides, 14(3), 1993, pp. 465-469
Since previous studies in vivo' have shown that oxytocin is metabolize
d by rat synaptic membrane-bound aminopeptidase- and endopeptidase-lik
e enzymes, the proteolytic conversion of oxytocin was studied in vivo
after microinjection in the rat hippocampus, a brain area that contain
s oxytocinergic nerve endings and receptors. Isolation of the formed p
eptide fragments from the injected brain area after homogenization and
adsorbtion on a Sep-Pak cartridge by high performance liquid chromato
graphy, and their characterization by amino acid analysis, revealed th
at, when oxytocin (50 nmol in 0.5 mul) was microinjected in the CA1 fi
eld of the rat hippocampus, only the N-terminal fragment oxytocin(1-8)
was formed in such amount that could be characterized. The microinjec
tion of [H-3-Tyr2]oxytocin (10 pmol) revealed that in addition to oxyt
ocin(1-8), free [H-3]tyrosine was formed. Taken together with previous
findings showing that C-terminal oxytocin fragments as well oxytocin(
1-8) are formed by membrane-bound aminopeptidases and endopeptidases i
n vitro, respectively, the results suggest that, in addition to aminop
eptidases, endopeptidase-like enzymes are involved in the proteolysis
of endogenous brain oxytocin.